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Abstract: Millions of years of evolution have fine-tuned the ability of venom peptides to
rapidly incapacitate both prey and potential predators. Toxicofera reptiles are characterized by
serous-secreting mandibular or maxillary glands with heightened levels of protein expression. These
glands are the core anatomical components of the toxicoferan venom system, which exists in myriad
points along an evolutionary continuum. Neofunctionalisation of toxins is facilitated by positive
selection at functional hotspots on the ancestral protein and venom proteins have undergone dynamic
diversification in helodermatid and varanid lizards as well as advanced snakes. A spectacular point on
the venom system continuum is the long-glanded blue coral snake (Calliophis bivirgatus), a specialist
feeder that preys on fast moving, venomous snakes which have both a high likelihood of prey
escape but also represent significant danger to the predator itself. The maxillary venom glands of C.
bivirgatus extend one quarter of the snake’s body length and nestle within the rib cavity. Despite the
snake’s notoriety its venom has remained largely unstudied. Here we show that the venom uniquely
produces spastic paralysis, in contrast to the flaccid paralysis typically produced by neurotoxic
snake venoms. The toxin responsible, which we have called calliotoxin (δ-elapitoxin-Cb1a), is a
three-finger toxin (3FTx). Calliotoxin shifts the voltage-dependence of NaV1.4 activation to more
hyperpolarised potentials, inhibits inactivation, and produces large ramp currents, consistent with its
profound effects on contractile force in an isolated skeletal muscle preparation. Voltage-gated sodium
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channels (NaV) are a particularly attractive pharmacological target as they are involved in almost all
physiological processes including action potential generation and conduction. Accordingly, venom
peptides that interfere with NaV function provide a key defensive and predatory advantage to a range
of invertebrate venomous species including cone snails, scorpions, spiders, and anemones. Enhanced
activation or delayed inactivation of sodium channels by toxins is associated with the extremely rapid
onset of tetanic/excitatory paralysis in envenomed prey animals. A strong selection pressure exists
for the evolution of such toxins where there is a high chance of prey escape. However, despite their
prevalence in other venomous species, toxins causing delay of sodium channel inhibition have never
previously been described in vertebrate venoms. Here we show that NaV modulators, convergent
with those of invertebrates, have evolved in the venom of the long-glanded coral snake. Calliotoxin
represents a functionally novel class of 3FTx and a structurally novel class of NaV toxins that will
provide significant insights into the pharmacology and physiology of NaV. The toxin represents
a remarkable case of functional convergence between invertebrate and vertebrate venom systems
in response to similar selection pressures. These results underscore the dynamic evolution of the
Toxicofera reptile system and reinforces the value of using evolution as a roadmap for biodiscovery.
Keywords: toxicofera; venom; evolution; neurotoxin; sodium channel; pharmacology
1. Introduction
Squamate reptiles are a research area of great controversy and debate at all levels, including
higher order organismal relationships [1]. Traditional frameworks based upon morphology [2–6] were
dramatically over-turned by genetic studies which revealed that the morphological plasticity of these
animals had obscured their authentic evolutionary relationships [7–16]. While the genetics are now
well-resolved, a form of scientific culture-war persists, with some adherents of morphologically
based taxonomy not modifying their position in the face of genetic evidence supporting the
paradigm shifts [17]. Attempts at reconstructing the evolutionary history by using a combination
of morphology, fossils, and genetics resulted in poorly resolved trees [18] that had significantly
different frameworks from those reconstructed using only genetic evidence [7–16]. The utilisation of
ambiguous morphological characters (which may be arbitrarily scored as divergent or convergent)
creates errors relative to the use of non-ambiguous genetic data. Use of such skewed trees results in
flawed conclusions when used to reconstruct the evolutionary history not only of the organisms but
also their associated venom systems, such as in [17,19]. Another study which examined tissue pattern
expressions of toxin and non-toxin homologues in an attempt to cast doubt on the shared ancestry
of reptile venom systems was methodologically flawed due to expression values being calculated
using replicate averages of values up to nearly 6,000-fold apart, only averaging N = 2 for many of the
experiments, and including failed experiments with zero values in N = 3 calculations (Supplementary
Tables S5–S9 of [20]).
Squamate reptiles are an extremely morphologically plastic clade, where dramatic variations in
size and shape [21] may not be an accurate reflection of the organismal genetic relationships [22–24].
One particular clade (Toxicofera) evolved a morphological feature not otherwise described in extant
squamates. The basic substrate for the evolution of reptile venom was the exaptation of existing
salivary glands in the common ancestor of toxicoferan reptiles (Anguimorpha and Iguania lizards plus
snakes), whereby the protein secreting region was increased in size and further segregated from the
mucus secreting region [25]. These glands remained in an apparently incipient state in most Iguania
except for vertebrate feeding lineages such as Anolis equestris, Pogona sp., and Chlamydosaurus Kingii.
In snakes and anguimorph lizards, however, extensive diversification has occurred [19,25–30].
In particular, this key evolutionary innovation under-pinned the explosive diversification of the
advanced snakes [10–15,27,30–36]. While initial venom proteins were pre-existing salivary proteins
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that were heightened in expression, such as CRiSP and kallikrein [27,37–39], the promiscuity venom
glands share with other secretory tissues allowed for lineage-specific expression of other protein
types [20,25–29,40–48] in addition to low-level reversal of expression of venom-gland-derived proteins
in other tissues [40]. For many toxin types, particularly those with high disulphide-bond ratios relative
to total amino acid content [37], evolutionary selection pressures resulted in neofunctionalisations that
produced a myriad of derived activities [41].
As with many other modes of evolution, periodically the venom proteins undergo punctuated
molecular evolution, dynamically diversifying into new functional forms early in their evolution, with
periods of stasis after that interrupted by further periods of Gouldian punctuated evolution [49–53].
Examples include elapids first arriving in Australia when it was a continent largely devoid of snakes
other than slow moving pythons and burrowing blind snakes [54]. Subsequent explosive organismal
diversification was paralleled by dramatic shifts in venom chemistry even between populations with
minimal organismal genetic variation [55,56].
Venom is a key evolutionary innovation, in myriad lineages, that diversifies in concert with
organismal morphological diversification [11,13–15,25–30,33,34,37,41,43–47,55–63]. This mechanical
and chemical interrelationship continues throughout the evolutionary history of a venomous lineage. In
some cases, explosive morphological changes apparently occur in an evolutionarily short period of time,
with the venom changing along with it in response to emergent selection pressures. Considerations
of the venom delivery system must also include the morphological features associated with prey
contact. Ambush feeding snakes such as most viperids rely on camouflage, which itself may be both
morphological (pattern) and chemical (control of smell emission) [64]. They typically have muscular
builds that facilitate fast and powerful strikes capable of driving their large, flexible fangs deep into a
prey item and delivering copious amounts of venom from their bulky venom glands. Elapid snakes,
however, are generally more agile as they are usually active foragers that deliver smaller amounts of
very toxic venom through short, rigid fangs connected to the relatively small venom glands.
As proteinaceous toxins are large in size, they necessitate delivery via a wound, however
small [26,27,58]. Thus, in addition to variation in the types and activities of proteins secreted by
the venom glands, there has been extensive evolutionary tinkering of all elements of this integrated
weapons system, including the glands themselves and the associated dentition. The morphological
plasticity of the glands has resulted in diverse forms. Plesiomorphic anguimorph lizard glands
are relatively unstructured despite containing large lumens in the well-defined protein-secreting
region, but two independent lineages of anguimorph lizards have evolved completely segregated,
membrane-encapsulated protein- and mucus-secreting regions [25,27,29]. In snakes there is
considerable variation in oral gland form and function, while in the advanced snakes the maxillary
venom glands have been fully segregated into distinct protein- and mucus-secreting tissues,
accompanied by extensive variation of features such as the relative presence, size, and shape of
liquid venom storage lumens [27,44,65].
While a venom delivering wound can be created by any form of tooth capable of penetrating skin,
in the advanced snakes enlarged rear teeth have independently evolved on multiple occasions and also
display extensive variation [44], in some cases accompanied by grooving that is convergent with that
seen in other extant and extinct venomous lineages including archosauriforms [66], conodonts [67],
sphenodons [68], insectivorous mammals such as shrews and solenodons [69–72], and bird-like
dinosaurs hypothesised to specialise in feeding upon on early birds [73].
Refinements of the ancestral snake venom system have included, on three independent occasions,
the evolution of high-pressure delivery systems terminating in hollow teeth, with the teeth in each case
being derived from enlarged rear teeth from within three different non-front-fanged lineages [27,74].
Within each of these front-fanged lineages, on at least one occasion (twice within the elapid snakes)
venom glands have become elongated to extend down into the neck region: Atractaspis within the
Lamprophiidae; Calliophis and Toxicocalamus within the Elapidae; and Causus within the Viperidae [27].
While Atractaspis and Causus venom glands are elongations of the venom glands extending directly
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down the neck, Calliophis elongated glands differ sharply in that a long duct extends down the neck
and then inside the ribs, with the glands located now inside the body cavity.
The influence of these elongations upon venom composition within each lineage has remained
uninvestigated. For example, the sarafotoxin from Atractaspis venoms are an example of a lineage
specific recruitment of protein type for use as a venom component, but it is unknown whether this
precedes or is subsequent to the diversification of the venom glands into an apomorphic long-glanded
state found only in one clade of Atractaspis, but not all. Similarly, Asian elapid snakes in the Calliophis
genus have plesiomorphic short-glanded (C. gracilis) and apomorphic long-glanded forms (C. bivirgatus
and C. intestinalis).
Coral snakes in the genus Calliophis feed upon other snakes, including other snake-eating
venomous species of Elapidae such as kraits (Bungarus) and king cobras (Ophiophagus) [75,76]. A unique
evolutionary scenario ensues, a chemical arms race between predator and prey in which the risk of
role reversal becomes a key selection pressure driving the evolution of toxins that rapidly render prey
incapable of retaliation or escape. Snakes that hunt animals capable of inflicting serious retaliatory
wounds often release their intended prey after envenomation. In this situation, selection may favour
the evolution of toxins that rapidly disable prey, either to prevent it moving too far to be recovered or
to prevent the possibility of it attacking and injuring the snake.
With its combination of electric blue dorsolateral stripes and neon red head, tail, and ventral
scales, the blue coral snake, Calliophis bivirgatus, is arguably one of the world’s most striking species of
snake (Figure 1a). An encounter with one is high on the list for many reptile enthusiasts and nature
photographers visiting southern Thailand, Malaysia, Singapore, and western Indonesia. The species
is of additional interest to anatomists and toxinologists studying the evolution and diversification
of the snake venom system as it (along with its congener C. intestinalis) possesses novel elongated
venom glands that extend for up to one quarter of the length of its body [77] (Figure 1b). It is also of
medical significance as, in spite of only a small handful of confirmed bites, it has been responsible
for at least one human fatality [76], is suspected of causing at least one more [78], and has no known
antivenom. In spite of these high levels of interest, the venom has been subject to relatively few
studies [79–81]. Those studies that examined the toxin content of the venom concluded that all the
three-finger toxins present were exclusively cytotoxic in their effects [80,81]. However, this limited
scope of activity attributed to the venom was reflective of the very narrow scope of assays performed
and cytotoxicity was largely assumed based on similarity of partial sequences to other toxin types
from other snakes rather than full activity characterisation. One study, which examined the usefulness
of Taiwan antivenom, preincubated the venom with antivenom (a clinically unrealistic situation) and
even then required very high doses to exert any meaningful level of inhibition [81].
2. Results and Discussion
In the present study, the pharmacology of blue coral snake venom was investigated. A form of
neurotoxicity, previously known from cone snail and scorpion venoms, was identified for the first
time from the venom of a snake. In the indirectly stimulated chick biventer cervicis nerve-muscle
assay, which is a skeletal muscle preparation, C. bivirgatus venom (10 µg/mL) produced large muscle
contractions and fasciculations (Figure 1c) which were significantly inhibited by the addition of
the sodium channel antagonist tetrodotoxin (Figure 1d; TTX; 0.1 µM) (Figure 1c). Activity-guided
fractionation using SH-SY5Y human neuroblastoma cells identified a peak dominated by a single
isotopic mass of 6725.89 Da as the active component (Figure 1d–g). Consistent with the effects of crude
venom in the chick biventer cervicis nerve-muscle assay, toxin-induced responses in neuroblastoma
cells were abolished by TTX (Control response, 3.12 ± 0.04 AFU; TTX (1 µM), 0.12 ± 0.03 AFU),
suggesting direct effects on voltage-gated sodium channels (Figure 1e). The amino acid sequence
of the active component, which we called calliotoxin or δ-elapitoxin-Cb1a, was determined
as: LECYDTIFKWHTMTCPEGQNLCFYYFTWRIFLVRGCTATCPVGYSHTHCCDTDKCNN using
a combination of Edman degradation sequencing and venom gland transcriptome analysis (Figure 2).
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Figure 1.  Isolation of calliotoxin  (δ‐elapitoxin‐Cb1a),  the  first NaV activator  from snake venom.  (a) 
Specimen  of  Calliophis  bivirgatus,  the  blue  coral  snake  (photo  by  Tom  Charlton);  (b)  Dissected 
preserved    112 cm Calliophis bivirgatus specimen with 29 cm elongated venom glands (arrows); (c) C. 
bivirgatus  crude  venom  (10  μg/mL)  elicits  rising  contractions  of  the  skeletal muscle  in  the  chick 
biventer cervicis nerve‐muscle preparation while abolishing nerve mediated contractions;  (d) Pre‐
treatment with tetrodotoxin (0.1 μM) prevents the  increase  in baseline tension elicited by crude C. 
bivirgatus venom. * p Value = 0.0272, significantly different from venom alone, unpaired t‐test.; (e) RP‐
HPLC fractionation of crude C. bivirgatus venom (150 μg) on a BDS Hypersil C18 column. Dotted line; 
gradient (25.6%–56.2% solvent B). Solid grey line shows elution of purified calliotoxin (green peak) 
under  identical  conditions. Arrow  indicates  active  fraction;  (f)  Left  axis  (green  line):  orthogonal 
purification of RP‐HPLC fraction containing calliotoxin on a Synergi‐Hydro RP column. Dotted line; 
gradient (36.5%–42.1% solvent B). Right axis (black line/filled circles): response of SH‐SY5Y cells to 
corresponding 20 s‐fractions. Fractions  indicated by blue circles were collected for sequencing and 
pharmacological analysis; (g) The fraction containing purified native calliotoxin  is dominated by a 
single isotopic mass of 6725.9 Da. 
Figure 1. Isolation of calliotoxin (δ-elapitoxin-Cb1a), the first NaV activator from snake venom.
(a) Specimen of Calliophis bivirgatus, the blue coral snake (photo by Tom Charlton); (b) Dissected
preserved 112 cm Calliophis bivirgatus specimen with 29 cm elongated venom glands (arrows);
(c) C. bivirgatus crude venom (10 µg/mL) elicits rising contractions of the skeletal muscle in the
chick biventer cervicis nerve-muscle preparation while abolishing nerve mediated contractions;
(d) Pre-treatment with tetrodotoxin (0.1 µM) prevents the increase in baseline tension elicited by
crude C. bivirgatus venom. * p Value = 0.0272, significantly different from venom alone, unpaired t-test;
(e) RP-HPLC fractionation of crude C. bivirgatus venom (150 µg) on a BDS Hypersil C18 column. Dotted
line; gradient (25.6%–56.2% solvent B). Solid grey line shows elution of purified calliotoxin (green
peak) under identical conditions. Arrow indicates active fraction; (f) Left axis (green line): orthogonal
purification of RP-HPLC fraction containing calliotoxin on a Synergi-Hydro RP column. Dotted line;
gradient (36.5%–42.1% solvent B). Right axis (black line/filled circles): response of SH-SY5Y cells to
corresponding 20 s-fractions. Fractions indicated by blue circles were collected for sequencing and
pharmacological analysis; (g) The fraction containing purified native calliotoxin is dominated by a
single isotopic mass of 6725.9 Da.
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The sequence calculated monotopic molecular weight is 6725.91 Da, which is in accord with
the mass spectrometry monoisotopic molecular weight of 6725.9 Da. Calliotoxin belongs to the class
of three-finger toxins (3FTx) but has low sequence homology to other known toxins in the family
(Figure 2).
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Figure 2. Sequence of calliotoxin (δ‐elapitoxin‐Cb1a) and the most closely related three‐finger toxins. 
Homology to known three‐finger toxins (3FTxs) was determined using BLAST and multiple sequence 
alignment conducted with CLUSTAL Omega (1.2.2). Calliotoxin (δ‐elapitoxin‐Cb1a; blue sequence) 
is  most  closely  related  to  ρ‐EPTX‐Dp1b  (P25518.1;  Dendroaspis  polylepis  polylepis;  50%  sequence 
identity),  ρ‐EPTX‐Dp1a  (P80495.1; Dendroaspis  polylepis  polylepis;  50%  sequence  identity),  ρ‐EPTX‐
Da1a  (P85092.1;  Dendroaspis  angusticeps;  49%  sequence  identity),  and  ρ‐EPTX‐Da1b  (P86419.1; 
Dendroaspis  angusticeps;  53%  sequence  identity),  three‐finger  toxins  with  activity  at  α1‐
adrenoreceptors,  as well  as muscarinic  toxin  3  (P81031.2; Dendroaspis  angusticeps;  49%  sequence 
identity)  targeting  the mAChR and Toxin CM‐12  (P62394.1; Naja haje haje; 42% sequence  identity), 
Cardiotoxin  7  (P49122.1; Naja  atra;  42%  sequence  identity),  and Three‐finger  toxin  6  (JAS05190.1; 
Micrurus tener; 47% sequence identity) with unknown pharmacological activity. Conserved ancestral 
cysteines shown in bold, disulphide‐bond pattern shown in black lines. 
3FTxs  have  diversified  into  forms  with  novel  pharmacology  that  include  post‐synaptic 
(muscarinic and nicotinic receptors), synaptic (acetylcholinesterase inhibitors), and presynaptic (L‐
type calcium channels) activities [61,82]. However, none to date have been reported with activity at 
voltage‐gated  sodium  channels.  Therefore,  we  further  examined  the  pharmacological  effect  of 
calliotoxin on HEK293 cells heterologously expressing NaV1.4, the NaV subtype essential for skeletal 
muscle function in mammals, using whole‐cell patch‐clamp recordings. Calliotoxin enhanced peak 
inward  current  and  delayed  inactivation  (Figure  3a,b),  causing  a  small  but  significant 
hyperpolarizing shift in the V1/2 of activation (control, −35.0 ± 0.1 mV; calliotoxin, −38.1 ± 0.3 mV; p < 
0.0001) and a significant depolarizing shift  in  the V1/2 of  fast  inactivation (control, −66.1 ± 0.5 mV; 
calliotoxin,  −61.6  ±  0.7 mV;  p  <  0.0001)  (Figure  3c). Calliotoxin  voltage‐dependently  delayed  the 
inactivation time constant (−20 mV pulse: control, 0.24 ± 0.02 ms; calliotoxin, 5.22 ± 0.9 ms; p < 0.05; 
Figure 3d), which resulted in a persistent current (−20 mV pulse: control, −6 ± 4 pA; calliotoxin, −536 
± 33 pA; p = 0.015; Figure 3e). In line with the above NaV activator activity, calliotoxin also significantly 
increased inward ramp currents (control, −143 ± 12 pA; calliotoxin, −728 ± 52 pA; p = 0.0004; Figure 
3f,g).   
These results demonstrate that calliotoxin acts directly at NaV in a manner reminiscent of other 
NaV activators from the venom of cone snails, scorpions, spiders, wasps, and anemones [26,83–90]. 
The potency is similar to that characterised for Australian hexathelid spiders such as funnel webs 
(Atrax and Hadronyche species) and the eastern mouse spider, which produce similar fasciculations 
in the neuromuscular organ bath assay (Missulena bradleyi) [91,92] (Figure 1c). Thus, calliotoxin is the 
first identified NaV activator from snake venom and represents a structurally novel class of NaV gating 
modifiers. While crotamine peptides from South American Crotalus species (rattlesnakes) had been 
previously thought to interact with sodium channels [93–95], in addition to being potent myotoxins, 
it has been recently observed that the neurotoxic activity is guided by potassium channel interactions 
[96–99].  A  PLA2  toxin  previously  isolated  from  the  Asian  pit‐viper  Gloydius  ussurensis  showed 
voltage‐dependence of activation of sodium channels in sensory neurons [100]. However, in contrast 
to calliotoxin,  this  toxin caused predominant effects on  the voltage‐dependence of activation and 
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3FTxs have diversified into forms with novel pharmacology that include post-synaptic (muscarinic
and nicotinic receptors), synaptic (acetylcholinesterase inhibitors), and presynaptic (L-type calcium
channels) activities [61,82]. However, none to date have been reported with activity at voltage-gated
sodium channels. Therefore, we further examined the pharmacological effect of calliotoxin on HEK293
cells heterologously expressing NaV1.4, the NaV subtype essential for skeletal muscle function in
mammals, using whole-cell patch-clamp recordings. Calliotoxin enhanced peak inward current
and delayed inactivation (Figure 3a,b), causing a small but significant hyperpolarizing shift in the
V1/2 of activation (control, −35.0 ± 0.1 mV; calliotoxin, −38.1 ± 0.3 mV; p < 0.0001) and a significant
depolarizing shift in the V1/2 of fast inactivation (control,−66.1 ± 0.5 mV; calliotoxin,−61.6 ± 0.7 mV;
p < 0.0001) (Figure 3c). Calliotoxin voltage-dependently delayed the inactivation time constant
(−20 mV pulse: control, 0.24 ± 0.02 ms; calliotoxin, 5.22 ± 0.9 ms; p < 0.05; Figure 3d), which resulted
in a persistent current (−20 mV pulse: control, −6 ± 4 pA; calliotoxin, −536 ± 33 pA; p = 0.015;
Figure 3e). In line with the above NaV activator activity, calliotoxin also significantly increased inward
ramp currents (control, −143 ± 12 pA; calliotoxin, −728 ± 52 pA; p = 0.0004; Figure 3f,g).
These results demonstrate that calliotoxin acts directly at NaV in a manner reminiscent of other
NaV activators from the venom of cone snails, scorpions, spiders, wasps, and anemones [26,83–90].
The potency is similar to that characterised for Australian hexathelid spiders such as funnel webs
(Atrax and Hadronyche species) and the eastern mouse spider, which produce similar fasciculations
in the neuromuscular organ bath assay (Missulena bradleyi) [91,92] (Figure 1c). Thus, calliotoxin is
the first identified NaV activator from snake venom and represents a structurally novel class of NaV
gating modifiers. While crotamine peptides from South American Crotalus species (rattlesnakes)
had been previously thought to interact with sodium channels [93–95], in addition to being potent
myotoxins, it has been recently observed that the neurotoxic activity is guided by potassium channel
interactions [96–99]. A PLA2 toxin previously isolated from the Asian pit-viper Gloydius ussurensis
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showed voltage-dependence of activation of sodium channels in sensory neurons [100]. However,
in contrast to calliotoxin, this toxin caused predominant effects on the voltage-dependence of activation
and decreased peak current. In addition, this toxin also affected voltage-gated potassium channels.
It remains to be determined whether calliotoxin also has effects on other members of the voltage-gated
ion channel family.
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Figure 3. Activity of calliotoxin (200 nM) in HEK-293 cells heterologously expressing hNaV1.4
assessed by automated patch clamping. (a) Representative trace of sodium currents before (upper)
and after addition of calliotoxin (lower) elicited by depolarizing steps between −80 and +60 mV in
10 mV increments. The red trace highlights the depolarizing step to −20 mV; (b) Current-voltage
relationship before and after the addition of calliotoxin; (c) Voltage-dependence of activation (circles)
and voltage-dependence of steady-state fast inactivation (squares) before and after addition of
calliotoxin; (d) Voltage-dependence of fast inactivation time constants before and after addition of
calliotoxin; (e) Average persistent current elicited 40–50 ms after a−20 mV depolarizing step before and
after addition of calliotoxin; (f) Representative trace of ramp sodium current before and after addition
of calliotoxin; (g) Peak inward current elicited by a depolarizing ramp (2.4 mV/ms) before and after
addition of calliotoxin. Data are shown as mean ± SEM with n = 3 replicates; (h) Calliotoxin-induced
effects are mediated through NaV channels. Calliotoxin-induced Ca2+ responses in SH-SY5Y cells were
inhibited by tetrodotoxin (TTX) (1 µM) but not the nAChR antagonist D-tubocurarine (10 µM), the M1
mAChR antagonist pirenzepine (100 µM), or the α1-adrenoreceptor antagonist prazosin (10 µM).
There is a general evolutionary trend for an inverse relationship between mechanical forms
of prey subjugation and chemical forms. In some predatory lineages, once a mechanical form of
prey capture has evolved, it is co-opted for use as a delivery system for venom. Spiders are one
such example, in which the ancestral mechanical form of predation using chelicerae to inflict fatal
wounds in prey items resulted in a selection pressure for the derived use as a venom delivery system,
with a subsequent reduction in chelicerae size [101,102]. Similarly, the elongated dentition used by
cleaner wrasse mimics from the Plagiotremus fangblenny genus for their unique parasitic feeding
strategy was co-opted for venom delivery in the Meiacanthus genus of fangblenny [103,104]. In other
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cases, a structural feature has been derived to become a venom-delivering apparatus, such as the
fin-supporting spines in fish [105]. In early toxicoferan venomous reptiles, the pre-existing teeth were
sufficient for the generation of a wound, allowing for low-pressure venom delivery via chewing, with
the array of extant dentition types subsequently evolving as refinements [27,58]. An alternate scenario
is one in which a hypertrophic mechanical structure is atrophied subsequent to the evolution of a
different part of the anatomy to serve as a venom-delivering structure. Examples include the large
claws of plesiomorphic scorpions accompanied by small stingers (telsons), relative to the gracile claws
of apomorphic scorpions which have large telsons [106], and octopus beaks and glands, with species
having large beaks having smaller glands than those which have small beaks [107,108].
The primary function of predatory venoms is the subjugation of prey items rather than
lethality [27]. From an evolutionary and practical perspective, there is little difference between an
unconscious or completely immobilized prey item and a dead one as the helpless former would simply
suffocate in the stomach after being swallowed. Thus, the primary shaping pressure in predatory
venom evolution is rapid prey subjugation rather than rapid lethality [1].
Chemical forms of prey subjugation allow for a decoupling of the physical interaction between
predator and prey. Snakes that hunt animals capable of inflicting serious retaliatory wounds often
release their intended prey after envenomation. In this situation, selection may favour the evolution of
toxins that rapidly disable prey, either to prevent it from moving too far to be recovered or to prevent
the possibility of it attacking and injuring the snake. For example, Northern Pacific rattlesnakes
(Crotalus oreganus) and inland taipans (Oxyuranus microlepidotus) both feed on rodents, which are
capable of inflicting life-threatening bite wounds upon snakes. Both species release their prey after
biting. Crotamine, a neurotoxin in the venom of the rattlesnake, paralyses the hind limbs of the
rodent in seconds, ensuring it is unable to travel far from the heavy bodied ambush-hunting snake
in the approximately two minutes it takes for it to die [109,110]. Inland taipans, which are fast
moving active hunters, face their rodent prey in confined underground spaces and thus are at
considerable risk of sustaining retaliatory injuries. Their venom is the most toxic (to rodents) of
any snake [111] and contains an exceptionally fast acting fXa:fVa coagulation enzyme complex, which
causes small clots to form throughout the rat’s circulatory system resulting in rapid knockdown via
stroke injury [27,112–114]. In human bite victims the same amount of venom is diluted into a much
larger blood volume, producing countless microthrombi which by themselves are too small to cause a
stroke but instead consume all of the clotting factors, with death the result of internal bleeding such as
cerebral hemorrhage [115].
Rapid knockdown effects may also evolve in situations where the cost of prey recovery is
particularly high due to the distance that might be traversed by dying prey. Mambas (genus
Dendroaspis) are arboreal elapid snakes that feed on birds, which they subdue with venom containing
unique kunitz peptide neurotoxins that rapidly cause excitatory paralysis through the inhibition
of voltage-dependent potassium channels, resulting in the sustained release of acetylcholine, while
3FTx inhibit acetylcholinesterase, further elongating the acetylcholine action [27,82,116–120]. Another
species of arboreal elapid snake, the Stephens’ banded snake (Hoplocephalus stephensi), uses natriuretic
peptide toxins to cause a precipitous drop in the blood pressure of prey animals [121]. In the case
of cone snails, the venom was first evolved for worm-hunting, with the subsequent evolution of
fish-specific venom for defence against predators, which was then co-opted on at least two occasions
for fish-specialist prey preference [122–124]. Piscivorus cone snails also risk being unable to recover
their prey if the fish are able to escape after envenomation—even if the fish only swims a small distance
before dying, the slow-moving snail faces a high risk of losing its meal to an opportune scavenger.
The risk of going hungry thus forms the selection pressure driving the evolution of the devastating
chemical weaponry of venoms.
NaV are widely expressed across animal phyla including in the invertebrate and vertebrate
nervous systems and are critically important for neuromuscular action potential conduction.
Accordingly, toxins that target NaV are widely found in venoms, with known families
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including the µ-conotoxins, µ-theraphotoxins, δ-conotoxins, α- and β- scorpion toxins, and
δ-theraphotoxins [26,83–90]. Although the mechanism of action of these toxins is distinct, all impair
normal NaV function, which critically depends on voltage-dependent activation and inactivation to
allow regulated Na+ influx. As a consequence, these toxins lead to catastrophic disruption of neuronal
or neuromuscular physiology. Although it initially seems surprising that a snake toxin would converge
on the same activity as that of toxins from cone snails, spiders, wasps, and scorpions, convergence in
molecular targeting is actually common amongst venomous organisms [26].
On a deeper theoretical level, these results have relevance to the debate regarding whether
evolution is contingent or predictable (e.g., [125,126]). In fact, as Daniel Dennett has pointed out [127],
it is both. Targeting NaV is, in Dennett’s terminology, a “Good Trick”. Since there is likely to be a
limited number of good tricks available to venomous organisms with the need to rapidly render prey
incapable of escape or retaliation, it is predictable that convergence will occur [1]. The possibilities
for evolutionary innovation, however, are constrained by historical contingency [128]. It is historical
contingency that makes it more likely (thus more predictable) that the novel activity observed in the
present study should emerge within the 3FTx, a toxin class typically under strong positive selection
within the Elapidae [129]. Thus we see a predictable convergence of molecular targeting arising
(predictably) within a toxin class “selected” by historical contingency—evolution is not predictable
rather than contingent, it is predictable because it is contingent.
In this case, the selection pressure driving this contingent and predictable evolutionary trajectory
is involvement with a prey animal that relies upon extreme coordination in its fight or flight response.
Cone snails have such an interaction with fish, mamba snakes with birds, and long-glanded blue
coral snakes with fast moving snakes, some of which are capable of venomous retaliatory actions
potentially lethal to the coral snakes. Thus, a novel, extreme selection pressure has driven the
venom evolution in a new direction. The hallmark of other elapid snake venoms are α-neurotoxins
that antagonistically bind to the post-synaptic nicotinic acetylcholine receptors to produce flaccid
paralysis, as is also the case in other venomous snakes lineages including gracile colubrid snakes with
enlarged rear-fangs [19,27,44,47,59,62,130–136]. Potent α-neurotoxicity preceded the evolution of the
high-pressure front-fanged system of elapids, as was revealed by our discovery of α-colubritoxin, the
first 3FTx isolated and characterized from a non-front-fanged lineage [59]. The toxin was of the same
form as had been studied in elapid snakes previously, where they had been called ‘weak neurotoxins’
since they were only weakly potent on mice [137–149]. A problem that had also confounded studies
of Boiga irregularis (brown tree snake), which had thus concluded they were non-venomous based on
their effects in a murine model [150–155]. However, all such plesiotypic 3FTx rich venoms were later
shown to be much more potent in a taxon-specific manner on diapsid (bird/reptile) than on synapsid
(mammal) post-synaptic nicotinic acetylcholine receptors, with some non-front-fanged snakes being as
potent as elapid snakes in such a taxon specific manner and thus were not ‘weak’ against natural prey
items [59,82,130,156–160].
In contrast, C. bivirgatus venom produces a new action with a net effect that is diametrically
opposed to the typical elapid snake mode of action: spastic paralysis that is potent on both the avian
and murine assays models used in this study. The early evolving elapid snake neurotoxic effect is
one of respiratory failure from a paralysed diaphragm because the snake toxins prevent acetylcholine
facilitating the diaphragm’s contraction, thus leaving it stuck in the non-contracted resting state.
In contrast, C. bivirgatus venom keeps sodium channel toxins open, blocking the closing of the channel
that would terminate the nerve transmission and allow the muscle to go back to the resting state. In this
case, the net effect is that muscles are stuck in the contracted activated state instead of the typical elapid
effect of being stuck in the non-contracted resting state. This is convergent with the rigid paralysis
cone snails produce when feeding upon fish or the muscle fasciculations characteristic of mamba
envenomations, both of which have been shaped by prey with high escape potential. The unique
selection pressure operating with the niche occupied by C. bivirgatus has resulted in the flipping of the
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neurotoxic polarity, with this novel effect evolving due to the selection pressure of fast moving prey
with high escape potential but also the potential for lethal retaliatory actions.
While the speed of action, and thus prey subjugation, are rapid, the question of relative toxicity
must still be considered. Why else would sodium channel delay of inactivation toxins not be
more common and only selected for in such extreme circumstances? Why has this only emerged
once in snakes? It very well may be that while the α-neurotoxins are slower to take effect, they
may be ultimately more effective as a consequence of their ability for sustained effect due to the
pathology being produced due to simple steric inhibition. This is reflective in C. bivirgatus having a
murine intravenous LD50 of 0.7–0.8 mg/kg [81] in comparison to that of a venom almost exclusively
containing classic α-neurotoxins such as Acanthophis antarcticus which has a murine intravenous
LD50 of 0.25 mg/kg [159,160]. Consistent with this, the black mamba (Dendroaspis polylepis), which
consume a higher percentage of rodents than birds in their diet, has a murine intravenous LD50 of
0.5 mg/kg, while the green mambas, which have a higher percentage of birds in their diets, and
thus would benefit from less toxic but more rapidly acting knock-down venoms, have LD50s of over
2.5 mg/kg for the Eastern green mamba (Dendroaspis angusticeps), 0.9 mg/kg for the Jameson’s mamba
(Dendroaspis jamesoni), and 1 mg/kg for the Western green mamba (Dendroaspis viridis) [161]. Such tests
reinforce that α-neurotoxicity is likely to be selected for due to its sustained paralytic effect, which is
ultimately lethal due to its persistence; whereby complete immobilization also results in death but
with the former being the outcome selected for by the shaping evolutionary pressures as there is no
functional difference between a prey in suspended animation and one that is deceased.
It is interesting to note that unlike plesiotypic 3FTx which retain all 10 ancestral cysteines
and are more potent to avian/reptilian post-synaptic nicotinic acetylcholine receptors than those
of mammals [59,61,82,130,132,134,135], the C. bivirgatus plesiotypic presynaptic sodium channel toxins
do not display taxon specific effects, as the crude venom and pure toxins were potent on both avian
neuromuscular organ bath preparations and mammalian ion-channels FLIPR assays (Figures 1 and 3).
Calliotoxin lacks the second and third plesiotypic cysteines (Figure 2), similar to that of the classic
Type I (aka: short-chain) α-neurotoxins, which also do not display a taxon specific effect [61,160].
This is consistent with the fact that while there are very few human C. bivirgatus envenomations
on record, the majority were lethal. Thus, while the venom may be three times less potent than
that of α-neurotoxic snakes, this is off-set by the massive venom yields produce by the elongated
venom glands, with dry weight single venom extraction quantities reaching 150 mg in this study for
large (>1.2 m) specimens. This massive venom yield proportional to the length of its slender body
is produced by the innovatively slender venom glands connected to the fang by a venom duct that
extends until the venom gland is inside the rib cavity (Figure 1b) with the venom gland compressing
musculature now wrapped completely around the gland, squeezing it from the back third in a manner
analogous to that of the cone snail venom system. Thus the venom diversification in this lineage is
paralleled by a morphological uniqueness, the evolution of which may have been driven by the same
selection pressures as that of the toxins themselves. Studies between this species and the short-glanded
C. gracilis and the long-glanded C. intestinalis will be revealing in regards to timing the venom gland
elongation versus the timing of the molecular evolution of this extremely novel new diversification of
the 3FTx framework. Regardless of the relative timing, the rapid interplay underscores that reptiles as a
general character are extremely morphologically plastic and that their venom systems also dynamically
evolve at all trophic levels.
A crucial difference between the two paralytic strategies (inhibitory/flaccid/limp or
excitatory/contracting/spastic) rests upon how long the effect can be sustained. In the case of nerve
transmission, certain ions move along an ion-gradient whenever a particular channel is opened at any
number of steps in the transmission of a nerve impulse. Over-stimulation has inbuilt rate-limiting
steps as the ion-pumps can only work at a finite rate to reset the ion-gradient. Thus, keeping the
sodium channel open by delaying its inactivation, the long-glanded blue coral snake toxins will sustain
this action only so long as there is a sufficient sodium gradient. Once isotonic levels for this ion
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are reached, there will be no more spontaneous action until the ion pumps re-establish a sufficient
gradient. Thus, the delay of presynaptic sodium channel inactivation is a resource which may be
exhausted. In contrast, α-neurotoxins bind to and block the post-synaptic nicotinic acetylcholine
receptors; an action that may be sustained for a much longer period as it does not require the
involvement of other molecules or chemical gradients. It is a case of antagonistic binding to the
receptors, with fundamental interactions such as electrostatic charge or hydrophobic attractions
determining the interaction strength. Once bound to the receptor, some toxins are virtually irreversible.
Such immobilizing paralysis would subjugate the prey items quite efficiently for an indefinite period,
thus having a marked degree of lethality. Therefore, there would exist a strong selection pressure to
maintain such a predatory weapon. This underscores just how radical a change in functionality has
occurred in C. bivirgatus venom.
The shift also parallels a shift in the metabolic state of the prey. Many Australian elapids snakes
feed on reptilian prey that is inactive/dormant at the time of the snake’s attack, and thus suffocation
through lethal lethargy inducing flaccid paralysis is an effective predatory strategy in elapid snakes [56].
Such a predatory strategy is also widely used in a myriad of venomous snakes that lack the apomorphic
high-pressure delivery systems [44,47,59,62,130–132,134–136]. In contrast, the long-glanded blue coral
snake feeds on other snakes that are at their highest activity level. Thus, the rapidity of effect becomes
the primary selection pressure [1].
Due to its extraordinary venom glands and extremely novel venom chemistry, this enigmatic
species may be considered as the epitome of toxicoferan reptile venom system derivation. Study of this
species increases our knowledge of venom evolution and demonstrates the relevance of studying toxins,
proteins unconstrained by endophysiological functions and under extreme selection pressures [56],
in order to gain insight into more general patterns of evolution. In addition, the results are of
considerable interest to those seeking to understand the mechanisms underlying NaV gating. These
results underscore the dynamic evolution of the Toxicofera reptile system at all trophic levels and
reinforces the value of using evolution as a roadmap for biodiscovery.
3. Materials and Methods
3.1. Materials
Specimens of the long-glanded blue coral snake (Calliophis bivirgatus) were captive animals of
Malaysia stock. All other reagents were from Sigma Aldrich (Castle Hill, Sydney, NSW, Australia)
unless otherwise specified.
3.2. Animal Ethics
All animal experiments used in this study were approved by the SOBS-B Monash University
Animal Ethics Committee MARP/2014/97 (1 December 2014).
3.3. Neurotoxicity Studies
Male chicks (4–10 days) were euthanised by CO2 and exsanguination. Both chick biventer cervicis
nerve muscle preparations were isolated and mounted on wire tissue holders under 1 g resting tension
in 5 mL organ baths containing physiological salt solution (NaCl, 118.4 mM; KCl, 4.7 mM; MgSO4,
1.2 mM; KH2PO4, 1.2 mM; CaCl2, 2.5 mM; NaHCO3, and 25 mM glucose, 11.1 mM), maintained at
34 ◦C and bubbled with 95% O2/5% CO2. Indirect twitches were evoked by electrical stimulation
of the motor nerve (supramaximal voltage, 0.2 ms, 0.1 Hz) using a Grass S88 stimulator (Grass
Instruments, Quincy, MA, USA). D-Tubocurarine (10 µM) was added, and subsequent abolition of
twitches confirmed selective stimulation of the motor nerve, after which thorough washing with
physiological salt solution was applied to re-establish twitches. The preparation was equilibrated for
30 min before the addition of venom, which was left in contact with the preparation for a maximum of
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3 h to test for slow developing effects. Efficacy of tetrodotoxin (TTX; 0.1 µM) was assessed via a 10 min
pre-incubation in the organ bath.
3.3.1. Assay-Guided Fractionation
Crude Calliophis bivirgatus venom (150 µg) was fractionated into thirty second fractions on
a ThermoScientific Hypersil (Scoresby, Vic, Australia) BDS C18 column (200 mm, 5 µm) using a
linear gradient from 5% to 70% solvent B over 60 min (solvent A, H2O/0.05% TFA; solvent B, 90%
acetonitrile/0.05% TFA) with a flow rate of 1 mL/min. Orthogonal purification of active fractions
was carried out using a Phenomenex Synergi Hydro-RP 80A HPLC column (Phenomenex, Torrance,
CA, USA) (250 × 4.6 mm, 4 µm) with flow rate of 0.7 mL/min and linear gradient from 30% to 50% B
over 40 min (solvent A, H2O/0.05% TFA; solvent B, 90% acetonitrile/0.05% TFA). Activity testing was
conducted as previously described [162] in human neuroblastoma SH-SY5Y cells (ECACC, Salisbury,
Wiltshire, UK) maintained at 37 ◦C/5% CO2 in Roswell Park Memorial Institute (RPMI) medium
containing 15% foetal bovine serum (FBS) and 2 mM L-glutamine. Cells were loaded with Calcium
4 No-Wash dye (Molecular Devices, Sunnvale, CA, USA) in 384-well black-walled imaging plates
(Sigma Aldrich, Castle Hill, NSW, Australia) 48 h after plating at a density of 50,000 cells/well and
incubated for 30 min at 37 ◦C. Freeze-dried fractions were resuspended in physiological salt solution
(PSS; composition: 140 mM NaCl, 11.5 mM glucose, 5.9 mM KCl, 1.4 mM MgCl2, 1.2 mM NaH2PO4,
5 mM NaHCO3, 1.8 mM CaCl2, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
pH 7.4) and added to dye-loaded cells using a FLIPRTETRA (Molecular Devices, Sunnyvale, CA, USA)
plate reader while measuring real-time fluorescence responses (excitation, 470–495 nm; emission,
515–575 nm). Selective activation of endogenously expressed NaV channels was confirmed through
inhibition of calliotoxin-induced responses by TTX (1 µM) and lack of effect of the nAChR antagonist
D-tubocurarine (10 µM), the M1 mAChR antagonist pirenzepine (100 µM) and the α1-adrenoreceptor
antagonist prazosin (10 µM) (Figure 3h).
3.3.2. Mass Spectrometry
Samples were separated using reversed-phase chromatography on a Dionex Ultimate 3000 RSLC
nano-system. Using a flow rate of 30 µL/min, samples were desalted on a Thermo PepMap 100
C18 trap (0.3 × 5 mm, 5 µm) for 5 min, followed by separation on a Acclaim PepMap RSLC C18
(150 mm × 75 µm) column at a flow rate of 300 nL/min with a gradient of 10%–95% buffer B over
60 min where buffer A = 1% ACN/0.1% FA and buffer B = 80% ACN/0.1% FA. Eluted molecules
were directly analysed on an Orbitap Elite mass spectrometer (Thermo, Brisbane, Australia) using
an NSI electrospray interface. Source parameters included a capillary temperature of 275 ◦C; S-Lens
RF level at 60%; source voltage of 2 kV and maximum injection times of 200 ms for MS. Data were
deconvoluted using Protein Deconvolution software (Thermo).
3.3.3. Edman Degradation and Venom Gland Transcriptomics
Edman degradation was carried out by the Australian Proteome Analysis Facility (APAF, Sydney,
Australia). Purified native calliotoxin was solubilised in ammonium bicarbonate (25 mM)/10% ACN
and reduced using DTT (25 mM) at 56 ◦C for 0.5 h, followed by alkylation using iodoacetamide
(55 mM) at room temperature for 0.5 h. The reaction mix was then desalted/purified by RP-HPLC
using a Zorbax 300SB-C18 column (3 × 150 mm, Agilent, Santa Clara, CA, USA). The volume was
reduced under vacuum and loaded onto a precycled, Biobrene-treated disc and subjected to 60 cycles
of Edman N-terminal sequencing using an Applied Biosystems 494 Procise Protein Sequencing System
(Applied Biosystems, Foster City, CA, USA), resulting in unambiguous identification of 47 amino acid
residues. Venom gland transcriptomics were conducted by the IMB Sequencing Facility (Institute
for Molecular Bioscience, The University of Queensland, St Lucia, Qld, Australia). Libraries were
prepared with the TruSeq Stranded mRNA kit (Illumina, San Diego, CA, USA), and were sequenced
on the Illumina NextSeq (Illumina) 500 using 2 × 150 bp reads and V2 chemistry. To identify the
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full sequence of δ-elapitoxin-Cb1a, forward and reverse sequences were merged using MacQIIME
(Werner Lab, SUNY Cortland, NY, USA) join_paired_end.py and matched to the sequence determined
by Edman degradation using standalone BLAST.
3.3.4. Electrophysiology
HEK-293 cells stably expressing hNaV1.4 (SB Drug Discovery, Glasgow, UK) were cultured in
MEM containing 10% v/v foetal bovine serum, supplemented with L-glutamine 2 mM and selection
antibiotics, as recommended by the manufacturer. Cells were grown in a humidified 5% CO2
incubator at 37 ◦C, grown to 70%–80% confluence, and passaged every three to four days using
TrypLE Express (Invitrogen, Scoresby, VIC, Australia). For electrophysiology experiments, cells were
dissociated by incubating with Detachin (Bio-Scientific, Kirrawee, NSW, Australia) at 37 ◦C for 5 min,
then resuspended in Ex-Cell ACF CHO Medium with 25 mM HEPES (Sigma-Aldrich, Castle Hill,
NSW, Australia) and allowed to recover with stirring for 30 min.
Whole-cell patch-clamp experiments were performed on a QPatch-16 automated
electrophysiology platform (Sophion Bioscience, Ballerup, Denmark) using 16-channel planar
patch chip plates (QPlates; Sophion Bioscience, Ballerup, Denmark) with a patch hole diameter of
1 µm and resistance of 2 ± 0.03 MΩ. Cell positioning and sealing parameters were set as follows:
positioning pressure −60 mbar, minimum seal resistance 0.1 GΩ, holding potential −100 mV, holding
pressure −20 mbar. Whole-cell currents were filtered at 5 kHz and acquired at 25 kHz.
The extracellular solution contained in mM: NaCl 145, KCl 4, CaCl2 2, MgCl2 1, HEPES 10, and
glucose 10; pH 7.4; osmolarity 305 mOsm. The intracellular solution contained in mM: CsF 140,
EGTA/CsOH 1/5, HEPES 10 and NaCl 10; pH 7.3; osmolarity 320 mOsm. Purified native calliotoxin
was diluted in extracellular solution to a concentration of 200 nM and incubated for 5 min. The effects
of calliotoxin were compared to pre-toxin control parameters in the same cell.
Current (I)-voltage (V) curves were obtained with a holding potential of −80 mV followed
by a pre-pulse of −100 mV for 50 ms and a series of 50 ms step pulses that ranged from −80 to
+60 mV in 5 mV increments before returning to a holding potential of −80 mV (repetition interval 5 s).
Conductance-voltage curves were obtained by calculating the conductance (G) at each voltage (V)
using the equation G = I/(V − Vrev), where Vrev is the reversal potential, and fitted with a Boltzmann
equation: GNa = GNa,max/1 + exp[(Vm − V1/2)/k], where GNa is the voltage-dependent sodium
conductance, GNa,max is the maximal sodium conductance, V1/2 is the potential at which activation is
half-maximal, Vm is the membrane potential, and k is the slope factor. Fast inactivation time constants
were calculated by fitting current decay traces obtained from the above I-V protocol with a single
exponential function, and persistent current was determined as the average current 40–50 ms after
pulse onset.
Voltage dependence of steady-state fast inactivation was measured using a series of 500 ms
pre-pulses, ranging from −120 to −10 mV in 10 mV increments, followed by a 20 ms pulse of
−20 mV to assess the available non-inactivated channels (repetition interval 30 s). Peak inward
currents (I) were normalized to the maximal inward current (Imax) and fitted using a Boltzmann
equation: I/Imax = 1/(1 + exp[(Vm − V1/2)/k)], where Imax is the maximal inward current, V1/2 is the
half-maximal sodium current, Vm is the pre-conditioning pulse potential, and k is the slope factor.
Ramp currents were evoked by a depolarization from a holding potential of −100 to +20 mV at a
rate of 2.4 mV/ms.
3.4. Data Analysis and Statistics
Unless otherwise stated, all data are expressed as the mean ± standard error of the mean (SEM)
determined from at least n = 3 replicates. FLIPRTetra results were converted to response over baseline
using ScreenWorks 3.2.0.14 (Molecular Devices, Sunnyvale, CA, USA) and plotted using GraphPad
Prism 6 (GraphPad Software, San Diego, CA, USA). Twitch heights were measured from the baseline in
two minute intervals. Responses were expressed as a percentage of twitch height prior to the addition
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of the peptide. Contractile responses to agonists obtained at the conclusion of the experiment were
measured and expressed as a percentage of the response obtained prior to the addition of peptide.
Where indicated, a one-way analysis of variance (ANOVA) followed by a Bonferroni-corrected post-hoc
test was used to determine statistical significance of responses. Statistical analysis was performed
using the GraphPad Prism 5.
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